胆汁中胆固醇结晶的调节。非手术治疗胆固醇性胆结石的意义。

Piero Portincasa, Antonio Moschetta, Karel J van Erpecum, Michele Vacca, Michele Petruzzelli, Giuseppe Calamita, Giuliano Meyer, Giuseppe Palasciano
{"title":"胆汁中胆固醇结晶的调节。非手术治疗胆固醇性胆结石的意义。","authors":"Piero Portincasa,&nbsp;Antonio Moschetta,&nbsp;Karel J van Erpecum,&nbsp;Michele Vacca,&nbsp;Michele Petruzzelli,&nbsp;Giuseppe Calamita,&nbsp;Giuliano Meyer,&nbsp;Giuseppe Palasciano","doi":"10.2174/1568008054064922","DOIUrl":null,"url":null,"abstract":"<p><p>The first step in cholesterol gallstone disease is precipitation of cholesterol crystals in bile. In gallbladder bile. cholesterol is normally solubilized together with bile salts and phospholipids to form mixed micellar structures. When cholesterol in bile is in excess, vesicles (i.e. phospholipid-cholesterol globular structures: liquid crystals) form which become supersaturated in cholesterol. Early aggregation and precipitation of cholesterol molecules into submicroscopic nuclei occurs from these supersaturated vesicles. This crucial step is followed by precipitation and agglomeration of cholesterol crystals which then become visible at light microscopy. Here we describe the mechanism of cholesterol crystallization and its modulation in vivo and in vitro. Recent advances on the role of ursodeoxycholate as an agent preventing the precipitation of cholesterol crystals in bile will be highligthed.</p>","PeriodicalId":84524,"journal":{"name":"Current drug targets. Immune, endocrine and metabolic disorders","volume":"5 2","pages":"177-84"},"PeriodicalIF":0.0000,"publicationDate":"2005-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1568008054064922","citationCount":"1","resultStr":"{\"title\":\"Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease.\",\"authors\":\"Piero Portincasa,&nbsp;Antonio Moschetta,&nbsp;Karel J van Erpecum,&nbsp;Michele Vacca,&nbsp;Michele Petruzzelli,&nbsp;Giuseppe Calamita,&nbsp;Giuliano Meyer,&nbsp;Giuseppe Palasciano\",\"doi\":\"10.2174/1568008054064922\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The first step in cholesterol gallstone disease is precipitation of cholesterol crystals in bile. In gallbladder bile. cholesterol is normally solubilized together with bile salts and phospholipids to form mixed micellar structures. When cholesterol in bile is in excess, vesicles (i.e. phospholipid-cholesterol globular structures: liquid crystals) form which become supersaturated in cholesterol. Early aggregation and precipitation of cholesterol molecules into submicroscopic nuclei occurs from these supersaturated vesicles. This crucial step is followed by precipitation and agglomeration of cholesterol crystals which then become visible at light microscopy. Here we describe the mechanism of cholesterol crystallization and its modulation in vivo and in vitro. Recent advances on the role of ursodeoxycholate as an agent preventing the precipitation of cholesterol crystals in bile will be highligthed.</p>\",\"PeriodicalId\":84524,\"journal\":{\"name\":\"Current drug targets. Immune, endocrine and metabolic disorders\",\"volume\":\"5 2\",\"pages\":\"177-84\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2174/1568008054064922\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current drug targets. Immune, endocrine and metabolic disorders\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1568008054064922\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug targets. Immune, endocrine and metabolic disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1568008054064922","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

胆固醇结石病的第一步是胆汁中胆固醇结晶的沉淀。在胆囊胆汁。胆固醇通常与胆盐和磷脂一起溶解,形成混合胶束结构。当胆汁中的胆固醇过量时,形成囊泡(即磷脂-胆固醇球状结构:液晶),使胆固醇过饱和。胆固醇分子的早期聚集和沉淀发生在这些过饱和的囊泡中。这一关键步骤之后是胆固醇晶体的沉淀和聚集,然后在光学显微镜下可以看到。在这里,我们描述了体内和体外胆固醇结晶及其调节的机制。熊脱氧胆酸盐作为一种预防胆汁中胆固醇结晶沉淀的药剂,其作用的最新进展将被强调。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease.

The first step in cholesterol gallstone disease is precipitation of cholesterol crystals in bile. In gallbladder bile. cholesterol is normally solubilized together with bile salts and phospholipids to form mixed micellar structures. When cholesterol in bile is in excess, vesicles (i.e. phospholipid-cholesterol globular structures: liquid crystals) form which become supersaturated in cholesterol. Early aggregation and precipitation of cholesterol molecules into submicroscopic nuclei occurs from these supersaturated vesicles. This crucial step is followed by precipitation and agglomeration of cholesterol crystals which then become visible at light microscopy. Here we describe the mechanism of cholesterol crystallization and its modulation in vivo and in vitro. Recent advances on the role of ursodeoxycholate as an agent preventing the precipitation of cholesterol crystals in bile will be highligthed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信